Existing epidemiological studies have shown that obesity‐related comorbidities, including altered adipokine secretion, chronic low‐grade inflammation, and abnormal insulin resistance, may represent potential mechanisms underlying the association between obesity and thyroid cancer [11, 12]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.